An obvious buy if you look at it. Huge upside from here and once it lists on the NASDAQ the valuations will naturally gravitate to the industrial average. 11x EBITDA Target of Phase 3 at $6.64B, gives us a target share price of roughly $18 in a couple years time. Something just to hold and leave for a long time.
